The WHO Pandemic Pact, under Article 19, seeks to prevent future crises but faces concerns over biosafety and rapid pathogen sharing through PABS. Debates on intellectual property, One Health dilution, and CBDR reflect tensions between innovation, equity, and global health security leadership.
Click to View MoreIndia is redefining global TB eradication efforts through rapid, point-of-care molecular diagnostics that enable early, accurate detection even in remote settings. Indigenous technologies such as Truenat have accelerated diagnosis, improved treatment initiation, and strengthened primary healthcare delivery. International case studies from Nigeria, Mozambique, and Tanzania demonstrate their global impact. However, challenges such as high operational costs, supply chain gaps, limited digital connectivity, and the need for integrated nutrition and social support remain. With sustained investment, stronger partnerships, and equitable access, India can lead the global shift toward inclusive and effective TB control.
Click to View More
© 2026 iasgyan. All right reserved